These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34834316)

  • 41. Chitosan nanocarriers for microRNA delivery and detection: A preliminary review with emphasis on cancer.
    Sargazi S; Siddiqui B; Qindeel M; Rahdar A; Bilal M; Behzadmehr R; Mirinejad S; Pandey S
    Carbohydr Polym; 2022 Aug; 290():119489. PubMed ID: 35550773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting of microRNAs for therapeutics.
    Stenvang J; Lindow M; Kauppinen S
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1197-200. PubMed ID: 19021524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptides used in the delivery of small noncoding RNA.
    Shukla RS; Qin B; Cheng K
    Mol Pharm; 2014 Oct; 11(10):3395-408. PubMed ID: 25157701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The microRNA (miRNA): overview of the RNA genes that modulate gene function.
    Ying SY; Chang DC; Lin SL
    Mol Biotechnol; 2008 Mar; 38(3):257-68. PubMed ID: 17999201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics.
    Muthiah M; Park IK; Cho CS
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1259-73. PubMed ID: 23826971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Artificial miRNAs as therapeutic tools: Challenges and opportunities.
    Kotowska-Zimmer A; Pewinska M; Olejniczak M
    Wiley Interdiscip Rev RNA; 2021 Jul; 12(4):e1640. PubMed ID: 33386705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry.
    Wang P; Zhou Y; Richards AM
    Theranostics; 2021; 11(18):8771-8796. PubMed ID: 34522211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design of expression vectors for RNA interference based on miRNAs and RNA splicing.
    Du G; Yonekubo J; Zeng Y; Osisami M; Frohman MA
    FEBS J; 2006 Dec; 273(23):5421-7. PubMed ID: 17076699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Adenoviral Vector as a Versatile Tool for Delivery and Expression of miRNAs.
    Scholz J; Weil PP; Pembaur D; Koukou G; Aydin M; Hauert D; Postberg J; Kreppel F; Hagedorn C
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells.
    Tay FC; Lim JK; Zhu H; Hin LC; Wang S
    Adv Drug Deliv Rev; 2015 Jan; 81():117-27. PubMed ID: 24859534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biogenesis, conservation, and function of miRNA in liverworts.
    Pietrykowska H; Sierocka I; Zielezinski A; Alisha A; Carrasco-Sanchez JC; Jarmolowski A; Karlowski WM; Szweykowska-Kulinska Z
    J Exp Bot; 2022 Jul; 73(13):4528-4545. PubMed ID: 35275209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene Silencing In Vitro and In Vivo Using Intronic MicroRNAs.
    Lin SL; Ying SY
    Methods Mol Biol; 2018; 1733():107-126. PubMed ID: 29435927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?
    Hossian AKMN; Mackenzie GG; Mattheolabakis G
    Nanomedicine (Lond); 2019 Nov; 14(21):2873-2889. PubMed ID: 31735124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in microRNAs: implications for gene therapists.
    Marquez RT; McCaffrey AP
    Hum Gene Ther; 2008 Jan; 19(1):27-38. PubMed ID: 18092919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.
    Seyhan AA
    Mol Biosyst; 2016 Jan; 12(1):295-312. PubMed ID: 26617199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miRNA and shRNA expression vectors based on mRNA and miRNA processing.
    Wu P; Wilmarth MA; Zhang F; Du G
    Methods Mol Biol; 2013; 936():195-207. PubMed ID: 23007510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High AU content: a signature of upregulated miRNA in cardiac diseases.
    Gupta R; Soni N; Patnaik P; Sood I; Singh R; Rawal K; Rani V
    Bioinformation; 2010 Sep; 5(3):132-5. PubMed ID: 21364793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Creating a flexible multiple microRNA expression vector by linking precursor microRNAs.
    Qiu X; Friedman JM; Liang G
    Biochem Biophys Res Commun; 2011 Jul; 411(2):276-80. PubMed ID: 21726537
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases.
    Rashid H; Hossain B; Siddiqua T; Kabir M; Noor Z; Ahmed M; Haque R
    Front Mol Biosci; 2020; 7():181. PubMed ID: 32850969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-based therapeutics for cancer.
    Wang V; Wu W
    BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.